1
|
Andler R, González-Arancibia F, Vilos C, Sepulveda-Verdugo R, Castro R, Mamani M, Valdés C, Arto-Paz F, Díaz-Barrera A, Martínez I. Production of poly-3-hydroxybutyrate (PHB) nanoparticles using grape residues as the sole carbon source. Int J Biol Macromol 2024; 261:129649. [PMID: 38266847 DOI: 10.1016/j.ijbiomac.2024.129649] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2023] [Revised: 01/15/2024] [Accepted: 01/18/2024] [Indexed: 01/26/2024]
Abstract
The production of poly-3-hydroxybutyrate (PHB) on an industrial scale remains a major challenge due to its higher production cost compared to petroleum-based plastics. As a result, it is necessary to develop efficient fermentative processes using low-cost substrates and identify high-value-added applications where biodegradability and biocompatibility properties are of fundamental importance. In this study, grape residues, mainly grape skins, were used as the sole carbon source in Azotobacter vinelandii OP cultures for PHB production and subsequent nanoparticle synthesis based on the extracted polymer. The grape residue pretreatment showed a high rate of conversion into reducing sugars (fructose and glucose), achieving up to 43.3 % w w-1 without the use of acid or external heat. The cultures were grown in shake flasks, obtaining a biomass concentration of 2.9 g L-1 and a PHB accumulation of up to 37.7 % w w-1. PHB was characterized using techniques such as Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), and differential scanning calorimetry (DSC). The formation of emulsified PHB nanoparticles showed high stability, with a particle size between 210 and 240 nm and a zeta potential between -12 and - 15 mV over 72 h. Owing to these properties, the produced PHB nanoparticles hold significant potential for applications in drug delivery.
Collapse
Affiliation(s)
- R Andler
- Escuela de Ingeniería en Biotecnología, Centro de Biotecnología de los Recursos Naturales (Cenbio), Universidad Católica del Maule, Talca, Chile.
| | - F González-Arancibia
- Escuela de Ingeniería en Biotecnología, Centro de Biotecnología de los Recursos Naturales (Cenbio), Universidad Católica del Maule, Talca, Chile
| | - C Vilos
- Laboratory of Nanomedicine and Targeted Delivery, School of Medicine, Universidad de Talca, Talca 3460000, Chile; Center for Nanomedicine, Diagnostic & Drug Development (cND3), Universidad de Talca, Talca 3460000, Chile; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago 8350709, Chile
| | - R Sepulveda-Verdugo
- Laboratory of Nanomedicine and Targeted Delivery, School of Medicine, Universidad de Talca, Talca 3460000, Chile; Center for Nanomedicine, Diagnostic & Drug Development (cND3), Universidad de Talca, Talca 3460000, Chile; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago 8350709, Chile
| | - R Castro
- Multidisciplinary Agroindustry Research Laboratory, Carrera de Ingeniería en Construcción, Instituto de Ciencias Químicas Aplicadas, Universidad Autónoma de Chile, Talca, Chile
| | - M Mamani
- Centro de Investigación de Estudios Avanzados del Maule (CIEAM), Vicerrectoría de Investigación y Postgrado, Universidad Católica del Maule, Chile
| | - C Valdés
- Centro de Investigación de Estudios Avanzados del Maule (CIEAM), Vicerrectoría de Investigación y Postgrado, Universidad Católica del Maule, Chile
| | - F Arto-Paz
- Escuela de Ingeniería en Biotecnología, Centro de Biotecnología de los Recursos Naturales (Cenbio), Universidad Católica del Maule, Talca, Chile
| | - A Díaz-Barrera
- Escuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile
| | - I Martínez
- Department of Chemical Engineering, Biotechnology and Materials, Centre for Biotechnology and Bioengineering (CeBiB), Universidad de Chile, Santiago, Chile
| |
Collapse
|
2
|
Wolbert F, Luebbert C, Sadowski G. The shelf life of ASDs: 2. Predicting the shelf life at storage conditions. Int J Pharm X 2023; 6:100207. [PMID: 37680879 PMCID: PMC10480311 DOI: 10.1016/j.ijpx.2023.100207] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Revised: 08/05/2023] [Accepted: 08/23/2023] [Indexed: 09/09/2023] Open
Abstract
Amorphous solid dispersions (ASDs) are a widely used formulation technology for poorly water-soluble active pharmaceutical ingredients (API). Depending on the API-polymer combination and API load in the ASD, the amorphous API might be thermodynamically metastable and crystallize over time. The crystallization onset is one critical factor that can define the shelf life of the ASD. Thus, for ASD formulations, long-term stability against crystallization of the API is of particular interest. This work presents a method for predicting the long-term physical stability of ASDs (crystallization onset time). The new approach combines the Johnson-Mehl-Avrami-Kolmogorov (JMAK) equation with classical nucleation theory. The shelf life predicted using the new approach depends on supersaturation (determined with PC-SAFT), viscosity (determined with WLF equation or Arrhenius equation) and two specific model parameters k' and B. The latter were fitted to a few fast crystallization-kinetics measurements above the glass transition of the ASD. An additional crystallization-kinetics measurement below the glass-transition temperature of the ASD was used to determine the Arrhenius parameters. Once all parameters are determined for a given API/polymer combination and manufacturing method, they are valid for any API load, temperature, and RH. The proposed approach allows predicting the shelf life (crystallization onset) of a potential ASD in early stage of development within a few days. It was successfully verified for ASDs stored at 25 °C and 10% RH or 60% RH.
Collapse
Affiliation(s)
- Friederike Wolbert
- INVITE GmbH, Drug Delivery innovation Center (DDiC), 51368 Leverkusen, Germany
- TU Dortmund University, Department of Biochemical and Chemical Engineering, Laboratory of Thermodynamics, Emil-Figge-Str. 70, D-44227 Dortmund, Germany
| | | | - Gabriele Sadowski
- TU Dortmund University, Department of Biochemical and Chemical Engineering, Laboratory of Thermodynamics, Emil-Figge-Str. 70, D-44227 Dortmund, Germany
| |
Collapse
|
3
|
Luebbert C, Stoyanov E. Tailored ASD destabilization - Balancing shelf life stability and dissolution performance with hydroxypropyl cellulose. Int J Pharm X 2023; 5:100187. [PMID: 37396620 PMCID: PMC10314205 DOI: 10.1016/j.ijpx.2023.100187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Revised: 05/31/2023] [Accepted: 06/02/2023] [Indexed: 07/04/2023] Open
Abstract
Amorphous solid dispersion (ASD) formulations are preferred enabling formulations for poorly water soluble active pharmaceutical ingredients (API) as they reliably enhance the dissolution behavior and solubility. Balancing a high stability against unwanted transformations such as crystallization and amorphous phase separation during storage on the one hand and optimizing the dissolution behavior of the formulation (high supersaturation and maintenance for long time) on the other hand are essential during formulation development. This study assessed the potential of ternary ASDs (one API and two polymers) containing the polymers hydroxypropyl cellulose together with poly(vinylpyrrolidone-co-vinyl acetate) (PVP VA64) or hydroxypropyl cellulose acetate succinate to stabilize the amorphously embedded APIs fenofibrate and simvastatin during storage and to enhance the dissolution performance. Thermodynamic predictions using the PC-SAFT model revealed for each combination of polymers the optimal polymer ratio, maximum API load that is thermodynamically stable as well as miscibility of the two polymers. The stability predictions were validated by three months enduring stability tests, followed by a characterization of the dissolution behavior. The thermodynamically most stable ASDs were found to be the ASDs with deteriorated dissolution performance. Within the investigated polymer combinations, physical stability and dissolution performance opposed each other.
Collapse
Affiliation(s)
| | - Edmont Stoyanov
- Nisso Chemical Europe GmbH, Berliner Allee 42, Düsseldorf D-40212, Germany
| |
Collapse
|
4
|
Bogdan C, Hales D, Cornilă A, Casian T, Iovanov R, Tomuță I, Iurian S. Texture analysis – a versatile tool for pharmaceutical evaluation of solid oral dosage forms. Int J Pharm 2023; 638:122916. [PMID: 37019322 DOI: 10.1016/j.ijpharm.2023.122916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2023] [Revised: 03/25/2023] [Accepted: 03/29/2023] [Indexed: 04/05/2023]
Abstract
In the past few decades, texture analysis (TA) has gained importance as a valuable method for the characterization of solid oral dosage forms. As a result, an increasing number of scientific publications describe the textural methods that evaluate the extremely diverse category of solid pharmaceutical products. Within the current work, the use of texture analysis in the characterization of solid oral dosage forms is summarised with a focus on the evaluation of intermediate and finished oral pharmaceutical products. Several texture methods are reviewed regarding the applications in mechanical characterization, and mucoadhesion testing, but also in estimating the disintegration time and in vivo specific features of oral dosage forms. As there are no pharmacopoeial standards for pharmaceutical products tested through texture analysis, and there are important differences between reported results due to different experimental conditions, the choice of testing protocol and parameters is challenging. Thereby, this work aims to guide the research scientists and quality assurance professionals involved in different stages of drug development into the selection of optimal texture methodologies depending on the product characteristics and quality control needs.
Collapse
Affiliation(s)
- Cătălina Bogdan
- Department of Dermopharmacy and Cosmetics, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 12 I. Creangă Street, 400010 Cluj-Napoca, Romania
| | - Dana Hales
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania.
| | - Andreea Cornilă
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania
| | - Tibor Casian
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania
| | - Rareș Iovanov
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania
| | - Ioan Tomuță
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania
| | - Sonia Iurian
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania
| |
Collapse
|
5
|
Downstream Processing of Itraconazole:HPMCAS Amorphous Solid Dispersion: From Hot-Melt Extrudate to Tablet Using a Quality by Design Approach. Pharmaceutics 2022; 14:pharmaceutics14071429. [PMID: 35890324 PMCID: PMC9323274 DOI: 10.3390/pharmaceutics14071429] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Revised: 07/01/2022] [Accepted: 07/04/2022] [Indexed: 11/17/2022] Open
Abstract
The downstream processing of hot-melt extruded amorphous solid dispersions (ASDs) into tablets is challenging due to the low tabletability of milled ASDs. Typically, the extrudate strand is sized before milling, as the strand cannot be fed directly into the milling system. At the lab scale, the strand can be sized by hand-cutting before milling. For scaling up, pelletizers or chill roll and flaker systems can be used to break strands. Due to the different techniques used, differences in milling and tablet compaction are to be expected. We present a systematic study of the milling and tableting of an extruded ASD of itraconazole with hypromellose acetate succinate (HPMCAS) as a carrier polymer. The strand was sized using different techniques at the end of the extruder barrel (hand-cutting, pelletizer, or chill roll and flaker) before being milled at varying milling speeds with varying screen sizes. The effects of these variables (sizing technology, milling speed, and screen size) on the critical quality attributes (CQAs) of the milled ASD, such as yield, mean particle size (D50), tablet compaction characteristics, and tablet dissolution, were established using response surface methodology. It was found that the CQAs varied according to sizing technology, with chill roll flakes showing the highest percentage yield, the lowest D50, and the highest tabletability and dissolution rate for itraconazole. Pearson correlation coefficient tests indicated D50 as the most important CQA related to tabletability and dissolution. For certain milling conditions, the milling of hand-cut filaments results in similar particle size distributions (PSDs) to the milling of pellets or chill roll flakes.
Collapse
|
6
|
Sivasankaran S, Jonnalagadda S. Levonorgestrel loaded biodegradable microparticles for injectable contraception: Preparation, characterization and modelling of drug release. Int J Pharm 2022; 624:121994. [PMID: 35809830 DOI: 10.1016/j.ijpharm.2022.121994] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Revised: 07/03/2022] [Accepted: 07/04/2022] [Indexed: 01/18/2023]
Abstract
The integration of mechanistic modeling and machine learning facilitates the understanding and engineering of drug release from controlled release systems. Here, we present hybrid models to predict the effect of drug loading on levonorgestrel release from spray-dried poly(L-lactic acid) microparticles. We developed three Monte Carlo methods that differ in the consideration of polymer's degradability and crystallinity, to simulate drug release from the matrices using the Python programming language. To build each method, we utilized data from the characterization of the particles, such as the actual drug content (ranges from 6% to 52%), size (Dv(50) ∼ 5 μm), and polymer crystallinity (ranges from 0% to 15%). We trained each method using drug release data from particles of 4 batches and derived appropriate machine learning models through regression analysis. Results indicate the contribution of drug diffusion and polymer degradation to drug release for particles of lower drug content (<20 %w/w). At higher drug loadings, particles encountered a combination of burst and diffusional release. We validated the predictive powers of the machine learning models by testing them against experimental data. This paper specifically highlights the power of hybrid modeling to engineer drug release for long-term contraception.
Collapse
Affiliation(s)
- Sowmya Sivasankaran
- Department of Pharmaceutical Sciences, University of the Sciences in Philadelphia, United States
| | | |
Collapse
|
7
|
Majumder S, Sun CC, Mara NA. Nanomechanical testing in drug delivery: Theory, applications, and emerging trends. Adv Drug Deliv Rev 2022; 183:114167. [PMID: 35183656 DOI: 10.1016/j.addr.2022.114167] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Revised: 02/01/2022] [Accepted: 02/14/2022] [Indexed: 11/01/2022]
Abstract
Mechanical properties play a central role in drug formulation development and manufacturing. Traditional characterization of mechanical properties of pharmaceutical solids relied mainly on large compacts, instead of individual particles. Modern nanomechanical testing instruments enable quantification of mechanical properties from the single crystal/particle level to the finished tablet. Although widely used in characterizing inorganic materials for decades, nanomechanical testing has been relatively less employed to characterize pharmaceutical materials. This review focuses on the applications of existing and emerging nanomechanical testing methods in characterizing mechanical properties of pharmaceutical solids to facilitate fast and cost-effective development of high quality drug products. Testing of pharmaceutical materials using nanomechanical techniques holds potential to develop fundamental knowledge in the structure-property relationships of molecular solids, with implications for solid form selection, milling, formulation design, and manufacturing. We also systematically discuss pitfalls and useful tips during sample preparation and testing for reliable measurements from nanomechanical testing.
Collapse
|
8
|
Pratto I, Busato MCA, Bittencourt PRS. Thermal and mechanical characterization of thermoplastic orthodontic aligners discs after molding process. J Mech Behav Biomed Mater 2021; 126:104991. [PMID: 34864573 DOI: 10.1016/j.jmbbm.2021.104991] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Revised: 11/17/2021] [Accepted: 11/18/2021] [Indexed: 10/19/2022]
Abstract
Polymeric aesthetic aligners were introduced in orthodontics as an innovative alternative to fixed appliances, however, their compositions and the thermal molding process may influence the biomechanical characteristics of these aligners. In this study four different clear aligner brands were used, ACE 035 Essix, C + Essix, Crystal 0.75 and Crystal 1.0, whose aim was to identify the thermal-processing influence on the mechanical and physicochemical properties of these materials, and to suggest a orthodontic sequence of wear for these appliances to achieve more effective treatment results. For the tensile tests the sample size calculation was based on probability distributions from the F test. The effect size used was 0.3, type 1 error of 0.05. Statistical Yield strength and Young's Modulus results were evaluated using the Shapiro-Wilk test. The groups were compared using the parametric test of analysis of variance, with Tukey post-test. Differences were statistically considered at the p < 0.05. The Infrared spectroscopy analysis showed no changes in the samples' chemical structure after thermal-processing. However, in the polypropylene aligner, differences were verified in the region attributed to the crystalline phase. Differential Scanning Calorimetry analysis for the same sample showed a crystallinity fraction decrease due to relaxation between polymer chains after molding. In the tensile tests evaluated, the tensile strength and 'Young's modulus presented higher values for aligners containing 100% polyethylene terephthalate glycol. Performing an analogy exercise of the properties of orthodontic wires used in conventional fixed appliances and, relating them to orthodontic plastics, aligners composed of different materials and/or thicknesses could be used in increasing sequence in terms of the modulus of elasticity, starting with C+, which has a lower elastic modulus value, using the ACE 035 as an intermediate and finishing with the Crystal 0.75 and 1.0, providing the desired stiffness to the aligners for the final phase.
Collapse
Affiliation(s)
- Isabella Pratto
- Universidade Estadual do Oeste do Paraná (UNIOESTE), Departamento de Odontologia, ZIP 85819-110, Cascavel, Paraná, Brazil
| | - Mauro Carlos Agner Busato
- Universidade Estadual do Oeste do Paraná (UNIOESTE), Departamento de Odontologia, ZIP 85819-110, Cascavel, Paraná, Brazil
| | - Paulo Rodrigo Stival Bittencourt
- Universidade Tecnológica Federal do Paraná (UTFPR), Departamento Acadêmico de Química, Bloco I4, ZIP 85884-000, Medianeira, Paraná, Brazil.
| |
Collapse
|
9
|
Iyer R, Petrovska Jovanovska V, Berginc K, Jaklič M, Fabiani F, Harlacher C, Huzjak T, Sanchez-Felix MV. Amorphous Solid Dispersions (ASDs): The Influence of Material Properties, Manufacturing Processes and Analytical Technologies in Drug Product Development. Pharmaceutics 2021; 13:1682. [PMID: 34683975 PMCID: PMC8540358 DOI: 10.3390/pharmaceutics13101682] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Revised: 09/06/2021] [Accepted: 09/13/2021] [Indexed: 12/14/2022] Open
Abstract
Poorly water-soluble drugs pose a significant challenge to developability due to poor oral absorption leading to poor bioavailability. Several approaches exist that improve the oral absorption of such compounds by enhancing the aqueous solubility and/or dissolution rate of the drug. These include chemical modifications such as salts, co-crystals or prodrugs and physical modifications such as complexation, nanocrystals or conversion to amorphous form. Among these formulation strategies, the conversion to amorphous form has been successfully deployed across the pharmaceutical industry, accounting for approximately 30% of the marketed products that require solubility enhancement and making it the most frequently used technology from 2000 to 2020. This article discusses the underlying scientific theory and influence of the active compound, the material properties and manufacturing processes on the selection and design of amorphous solid dispersion (ASD) products as marketed products. Recent advances in the analytical tools to characterize ASDs stability and ability to be processed into suitable, patient-centric dosage forms are also described. The unmet need and regulatory path for the development of novel ASD polymers is finally discussed, including a description of the experimental data that can be used to establish if a new polymer offers sufficient differentiation from the established polymers to warrant advancement.
Collapse
Affiliation(s)
- Raman Iyer
- Technical Research and Development, c/o Global Drug Development, Novartis Pharmaceuticals Corp., One Health Plaza, East Hanover, NJ 07936, USA
| | - Vesna Petrovska Jovanovska
- Product Development, Lek Pharmaceuticals d.d., Verovškova 57, 1526 Ljubljana, Slovenia; (V.P.J.); (K.B.); (M.J.); (T.H.)
| | - Katja Berginc
- Product Development, Lek Pharmaceuticals d.d., Verovškova 57, 1526 Ljubljana, Slovenia; (V.P.J.); (K.B.); (M.J.); (T.H.)
| | - Miha Jaklič
- Product Development, Lek Pharmaceuticals d.d., Verovškova 57, 1526 Ljubljana, Slovenia; (V.P.J.); (K.B.); (M.J.); (T.H.)
| | - Flavio Fabiani
- Technical Research and Development, c/o Global Drug Development, Novartis Pharma AG, Lichtstrasse 35, CH-4056 Basel, Switzerland; (F.F.); (C.H.)
| | - Cornelius Harlacher
- Technical Research and Development, c/o Global Drug Development, Novartis Pharma AG, Lichtstrasse 35, CH-4056 Basel, Switzerland; (F.F.); (C.H.)
| | - Tilen Huzjak
- Product Development, Lek Pharmaceuticals d.d., Verovškova 57, 1526 Ljubljana, Slovenia; (V.P.J.); (K.B.); (M.J.); (T.H.)
| | | |
Collapse
|
10
|
Flügel K, Schmidt K, Mareczek L, Gäbe M, Hennig R, Thommes M. Impact of incorporated drugs on material properties of amorphous solid dispersions. Eur J Pharm Biopharm 2021; 159:88-98. [PMID: 33383170 DOI: 10.1016/j.ejpb.2020.12.017] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2020] [Revised: 12/19/2020] [Accepted: 12/21/2020] [Indexed: 11/16/2022]
Abstract
Formulation development of amorphous solid dispersions (ASD) still is challenging although several poorly water-soluble drugs have been marketed using this technique. During development of novel drugs, the selection of the preparation technique and polymer matrix is commonly performed for the certain drug via screening tools. However, if general trends regarding material properties are to be investigated, this approach is not beneficial, although often utilized in literature. The main component of the ASD usually is the polymer and thus it predominantly determines the material properties of the system. Therefore, to study the impact of different drugs and their drug loads on mechanical properties and wettability, three poorly soluble model drugs with drug loads ranging from 10% to 40% were incorporated into copovidone via hot-melt extrusion. The obtained extrudates were subsequently characterized regarding mechanical properties by applying diametral compression test and nanoindentation and the results were compared to the performance during tablet compression. Incorporation of all tested drugs resulted in a similar increase in brittleness of the ASDs, whereas the Young's modulus and hardness changed differently in dependence of the incorporated drug. These observations correlated well with the performance during tablet compression and it was concluded, that the brittleness seemed to be the predominant factor influencing the compression behavior of copovidone-based ASDs. Furthermore, the degree of water absorption and wettability was assessed by applying dynamic vapor sorption experiments and contact angle measurements. Here, the incorporated drugs impacted the contact angle to different degrees and a strong correlation between the contact angle and disintegration time was observable. These results highlight the importance of thorough characterization of the ASDs as it helps to predict their performance during tablet compression and thus facilitates the optimal selection of excipients.
Collapse
Affiliation(s)
- Karsten Flügel
- Faculty of Biochemical and Chemical Engineering, Laboratory of Solids Process Engineering, Technical University Dortmund, Emil-Figge-Str. 68, 44227 Dortmund, Germany; Department of Pharmaceutical Technologies, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany
| | - Katharina Schmidt
- Department of Pharmaceutical Technologies, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany
| | - Lena Mareczek
- Department of Pharmaceutical Technologies, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany
| | - Michael Gäbe
- Department of Pharmaceutical Technologies, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany
| | - Robert Hennig
- Department of Pharmaceutical Technologies, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany
| | - Markus Thommes
- Faculty of Biochemical and Chemical Engineering, Laboratory of Solids Process Engineering, Technical University Dortmund, Emil-Figge-Str. 68, 44227 Dortmund, Germany.
| |
Collapse
|